Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis
The aim of the present study was to evaluate plasma levels of chemerin, myeloperoxidase (MPO), fibroblast growth factor-21 (FGF-21), thioredoxin reductase-1 (TrxR1), and matrix metallopeptidase-9 (MMP-9) in acquired aortic valve (AoV) stenosis patients to determine correlations between the studied c...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-05-01
|
Series: | Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences |
Subjects: | |
Online Access: | https://doi.org/10.2478/prolas-2019-0016 |
id |
doaj-7d9c285294da4957b981bb6c8e475389 |
---|---|
record_format |
Article |
spelling |
doaj-7d9c285294da4957b981bb6c8e4753892021-09-05T14:01:14ZengSciendoProceedings of the Latvian Academy of Sciences. Section B, Natural Sciences1407-009X2019-05-0173210010610.2478/prolas-2019-0016prolas-2019-0016Prognostic Utility Of Novel Biomarkers in Aortic Valve StenosisTretjakovs Pēteris0Hofmanis Juris1Hofmane Dace2Krieviņa Gita3Blumfelds Leons4Mackēvičs Vitolds5Lejnieks Aivars6Bahs Guntis7Faculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaFaculty of Medicine, Rīga Stradiņš University, 16 Dzirciema Str., Rīga, LV-1007, LatviaThe aim of the present study was to evaluate plasma levels of chemerin, myeloperoxidase (MPO), fibroblast growth factor-21 (FGF-21), thioredoxin reductase-1 (TrxR1), and matrix metallopeptidase-9 (MMP-9) in acquired aortic valve (AoV) stenosis patients to determine correlations between the studied cellular factors, and also clarify the predictive values of these factors as biomarkers in AoV stenosis. AoV stenosis patients were classified into three groups: 17 patients with mild AoV stenosis; 19 with moderate and 15 with severe AoV stenosis. Twenty-four subjects without AoV stenosis were selected as a control group. Our findings suggest that AoV stenosis might be associated with increased chemerin, TrxR1, MPO, and FGF-21 levels in plasma. Moreover, these factors and also MMP-9 already reached statistically significantly elevated levels in the early stages of AoV stenosis, but MPO levels were more pronounced in patients with moderate and severe AoV stenosis. Chemerin was correlated with all of the studied cytokines; TrxR1 and MMP-9 were correlated with several other cellular factors. Our findings (by ROC analysis) suggest that MPO and chemerin might serve as specific and sensitive biomarkers for AoV stenosis without grading the severity, but, in relation to mild AoV stenosis, TrxR1, FGF-21, and MMP-9 also reached good or moderate levels as biomarkers. The cellular factors might serve as novel diagnostic and prognostic biomarkers in AoV stenosis patients, while chemerin and MPO may be more powerful.https://doi.org/10.2478/prolas-2019-0016aortic valve stenosischemerinmyeloperoxidasefibroblast growth factor-21thioredoxin reductase-1matrix metalloproteinase-9 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tretjakovs Pēteris Hofmanis Juris Hofmane Dace Krieviņa Gita Blumfelds Leons Mackēvičs Vitolds Lejnieks Aivars Bahs Guntis |
spellingShingle |
Tretjakovs Pēteris Hofmanis Juris Hofmane Dace Krieviņa Gita Blumfelds Leons Mackēvičs Vitolds Lejnieks Aivars Bahs Guntis Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences aortic valve stenosis chemerin myeloperoxidase fibroblast growth factor-21 thioredoxin reductase-1 matrix metalloproteinase-9 |
author_facet |
Tretjakovs Pēteris Hofmanis Juris Hofmane Dace Krieviņa Gita Blumfelds Leons Mackēvičs Vitolds Lejnieks Aivars Bahs Guntis |
author_sort |
Tretjakovs Pēteris |
title |
Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis |
title_short |
Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis |
title_full |
Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis |
title_fullStr |
Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis |
title_full_unstemmed |
Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis |
title_sort |
prognostic utility of novel biomarkers in aortic valve stenosis |
publisher |
Sciendo |
series |
Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences |
issn |
1407-009X |
publishDate |
2019-05-01 |
description |
The aim of the present study was to evaluate plasma levels of chemerin, myeloperoxidase (MPO), fibroblast growth factor-21 (FGF-21), thioredoxin reductase-1 (TrxR1), and matrix metallopeptidase-9 (MMP-9) in acquired aortic valve (AoV) stenosis patients to determine correlations between the studied cellular factors, and also clarify the predictive values of these factors as biomarkers in AoV stenosis. AoV stenosis patients were classified into three groups: 17 patients with mild AoV stenosis; 19 with moderate and 15 with severe AoV stenosis. Twenty-four subjects without AoV stenosis were selected as a control group. Our findings suggest that AoV stenosis might be associated with increased chemerin, TrxR1, MPO, and FGF-21 levels in plasma. Moreover, these factors and also MMP-9 already reached statistically significantly elevated levels in the early stages of AoV stenosis, but MPO levels were more pronounced in patients with moderate and severe AoV stenosis. Chemerin was correlated with all of the studied cytokines; TrxR1 and MMP-9 were correlated with several other cellular factors. Our findings (by ROC analysis) suggest that MPO and chemerin might serve as specific and sensitive biomarkers for AoV stenosis without grading the severity, but, in relation to mild AoV stenosis, TrxR1, FGF-21, and MMP-9 also reached good or moderate levels as biomarkers. The cellular factors might serve as novel diagnostic and prognostic biomarkers in AoV stenosis patients, while chemerin and MPO may be more powerful. |
topic |
aortic valve stenosis chemerin myeloperoxidase fibroblast growth factor-21 thioredoxin reductase-1 matrix metalloproteinase-9 |
url |
https://doi.org/10.2478/prolas-2019-0016 |
work_keys_str_mv |
AT tretjakovspeteris prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT hofmanisjuris prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT hofmanedace prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT krievinagita prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT blumfeldsleons prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT mackevicsvitolds prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT lejnieksaivars prognosticutilityofnovelbiomarkersinaorticvalvestenosis AT bahsguntis prognosticutilityofnovelbiomarkersinaorticvalvestenosis |
_version_ |
1717810525146972160 |